NCT00626314View on ClinicalTrials.gov

Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System

PHASE2UnknownINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

August 31, 2010

Conditions
Ischemic Cardiomyopathy
Interventions
BIOLOGICAL

myoblast

autologous myoblast

BIOLOGICAL

sham

sham injection procedure

Trial Locations (1)

85297

Mercy Gilbert, Gilbert

Sponsors

Lead Sponsor

Mytogen, Inc.
All Listed Sponsors
lead

Mytogen, Inc.

INDUSTRY

NCT00626314 - Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System | Biotech Hunter | Biotech Hunter